Gross Profit Trends Compared: AbbVie Inc. vs Pharming Group N.V.

Gross Profit Trends: AbbVie Inc. vs Pharming Group N.V.

In the competitive landscape of the pharmaceutical industry, understanding gross profit trends is crucial for investors and stakeholders. Over the past decade, AbbVie Inc. has demonstrated a robust growth trajectory, with its gross profit increasing by approximately 118% from 2014 to 2023. In contrast, Pharming Group N.V., while showing growth, has maintained a much smaller scale, with its gross profit rising by nearly 920% over the same period, albeit from a significantly lower base.

A Decade of Growth

AbbVie Inc.'s gross profit peaked in 2022, reaching a remarkable 40 billion, before slightly declining in 2023. Meanwhile, Pharming Group N.V. saw its highest gross profit in 2023, marking a steady upward trend. This comparison highlights the differing scales and growth dynamics of these two pharmaceutical giants, offering valuable insights for market analysts and investors.